Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials.

Gissy JJ, Johnson T, Fox DJ, Kumar A, Ciafaloni E, van Essen AJ, Peay HL, Martin A, Lucas A, Finkel RS; MD STARnet.

Neuromuscul Disord. 2017 Oct;27(10):905-910. doi: 10.1016/j.nmd.2017.06.002. Epub 2017 Jul 21.

PMID:
28739181
2.

Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy.

Kim S, Zhu Y, Romitti PA, Fox DJ, Sheehan DW, Valdez R, Matthews D, Barber BJ; MD STARnet.

Neuromuscul Disord. 2017 Aug;27(8):730-737. doi: 10.1016/j.nmd.2017.05.019. Epub 2017 Jun 5.

PMID:
28645460
3.

Respiratory Care Received by Individuals With Duchenne Muscular Dystrophy From 2000 to 2011.

Andrews JG, Soim A, Pandya S, Westfield CP, Ciafaloni E, Fox DJ, Birnkrant DJ, Cunniff CM, Sheehan DW; Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).

Respir Care. 2016 Oct;61(10):1349-59. doi: 10.4187/respcare.04676. Epub 2016 Aug 9.

4.

Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy.

Lamb MM, West NA, Ouyang L, Yang M, Weitzenkamp D, James K, Ciafaloni E, Pandya S, DiGuiseppi C; Muscular Dystrophy Surveillance, Research, and Tracking Network (MD STARnet).

J Pediatr. 2016 Jun;173:207-213.e3. doi: 10.1016/j.jpeds.2016.02.067. Epub 2016 Mar 30.

5.

Neurobehavioral Concerns Among Males with Dystrophinopathy Using Population-Based Surveillance Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network.

Caspers Conway K, Mathews KD, Paramsothy P, Oleszek J, Trout C, Zhang Y, Romitti PA; MD STARnet.

J Dev Behav Pediatr. 2015 Jul-Aug;36(6):455-63. doi: 10.1097/DBP.0000000000000177.

6.

Prevalence of Duchenne and Becker muscular dystrophies in the United States.

Romitti PA, Zhu Y, Puzhankara S, James KA, Nabukera SK, Zamba GK, Ciafaloni E, Cunniff C, Druschel CM, Mathews KD, Matthews DJ, Meaney FJ, Andrews JG, Conway KM, Fox DJ, Street N, Adams MM, Bolen J; MD STARnet.

Pediatrics. 2015 Mar;135(3):513-21. doi: 10.1542/peds.2014-2044. Epub 2015 Feb 16. Erratum in: Pediatrics. 2015 May;135(5):945.

7.

Corticosteroid Treatments in Males With Duchenne Muscular Dystrophy: Treatment Duration and Time to Loss of Ambulation.

Kim S, Campbell KA, Fox DJ, Matthews DJ, Valdez R; MD STARnet.

J Child Neurol. 2015 Sep;30(10):1275-80. doi: 10.1177/0883073814558120. Epub 2014 Nov 20.

8.

Trends with corticosteroid use in males with Duchenne muscular dystrophy born 1982-2001.

Fox DJ, Kumar A, West NA, DiRienzo AG, James KA, Oleszek J; Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).

J Child Neurol. 2015 Jan;30(1):21-6. doi: 10.1177/0883073813517263. Epub 2014 Mar 28.

PMID:
24682290
9.

Reproductive patterns among mothers of males diagnosed with Duchenne or Becker muscular dystrophy.

Nabukera SK, Romitti PA, Caspers KM, Street N, Cunniff C, Mathews KD, Fox DJ, Puzhankara S, Ciafaloni E, James KA, Su Y; MD STARnet.

Am J Med Genet A. 2013 Jan;161A(1):70-5. doi: 10.1002/ajmg.a.35682. Epub 2012 Dec 13.

PMID:
23239595
10.

Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy.

Nabukera SK, Romitti PA, Campbell KA, Meaney FJ, Caspers KM, Mathews KD, Sherlock SM, Puzhankara S, Cunniff C, Druschel CM, Pandya S, Matthews DJ, Ciafaloni E; MD STARnet.

J Child Neurol. 2012 Jun;27(6):734-40. doi: 10.1177/0883073811426501. Epub 2011 Dec 7.

PMID:
22156783
11.

Use of corticosteroids in a population-based cohort of boys with duchenne and becker muscular dystrophy.

Matthews DJ, James KA, Miller LA, Pandya S, Campbell KA, Ciafaloni E, Mathews KD, Miller TM, Cunniff C, Meaney FJ, Druschel CM, Romitti PA, Fox DJ; MD STARnet.

J Child Neurol. 2010 Nov;25(11):1319-24. doi: 10.1177/0883073810362762. Epub 2010 Mar 5.

PMID:
20207610

Supplemental Content

Loading ...
Support Center